Clinical Trials Directory

Trials / Completed

CompletedNCT00547170

Doxycycline Prophylaxis at Vacuum Aspiration Trial

Efficacy and Side-Effects of Two Dosing Regimens of Doxycycline at Surgical Abortion: A Randomized Double-Blind Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
1,000 (actual)
Sponsor
University of Pittsburgh · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is a randomized, double-blinded, controlled trial comparing two regimens of doxycycline for the prevention of infection after surgical abortion. One thousand women undergoing surgical abortion in the first trimester will be enrolled from the clinic at Tu Du Hospital, Ho Chi Minh City, Vietnam. The standard regimen has been 100 mg twice daily for 5 days after the abortion. Subjects will be randomized to the standard regimen or to take 200 mg doxycycline pre-operatively. Subjects found to have a positive Chlamydia EIA test will receive a 7-day course of doxycycline regardless of study group. Subjects will complete questionnaires of symptoms, including nausea and emesis in the recovery room after the procedure and at a single follow-up visit two weeks later. The primary outcome will be infection after abortion, defined below. Analyses will be performed including and excluding Chlamydia-positive subjects. Secondary outcomes will be the proportion with nausea, emesis, and other side-effects.

Conditions

Interventions

TypeNameDescription
DRUGDoxycycline pre-operativelyTwo capsules of Doxycycline 100 mg before vacuum aspiration Placebo "100 mg" twice daily for 5 days after vacuum aspiration (appearance of capsules is the same for both groups)
DRUGDoxycycline post-operativelyTwo capsules of placebo "100 mg" before vacuum aspiration Doxycycline 100 mg twice daily for 5 days after vacuum aspiration (appearance of capsules is the same for both groups)

Timeline

Start date
2007-01-01
Primary completion
2008-03-01
Completion
2008-03-01
First posted
2007-10-22
Last updated
2008-05-16

Locations

1 site across 1 country: Vietnam

Source: ClinicalTrials.gov record NCT00547170. Inclusion in this directory is not an endorsement.